ASHPOfficial

This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) and the Section of Pharmacy Practice Leaders (SPPL) will inform listeners about developing the pipeline from residents, mid-level managers, and upper-level pharmacy executives for hospital and health system pharmacy leadership by engaging two established pharmacy executives and two pharmacy administration and leadership residents. Listeners will learn perspectives on the leadership pipeline for health system pharmacy, key drivers, and thoughts on leadership considerations for the continued advancement of health system pharmacy practice. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast centers on actionable steps residency program directors (RPDs) can take to prepare for audits with fewer surprises. It highlights concrete practices — like tightening documentation workflows, tracking how dollars move through the institution, and building audit-ready files — that may help programs stay compliant while running more smoothly. The episode is designed as a straightforward refresher for RPDs who may benefit from more clarity on regulatory expectations.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This session discusses the potential sites of action and benefits for GLP-1 agonists (GLP-1a) in the pathology of two neurodegenerative disorders, Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). This session will also review the published and pending clinical literature of FDA approved GLP-1a use in AD and PD.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast focuses on on strategies to use technology to increase access to pharmacy care. Strategies include optimizing use of the electronic medical record for patient communication, use of prescription pick up kiosks to facilitate prescription access, and use of telepharmacy and remote pharmacies to promote pharmacy access. The positive impact to patient care will be highlighted throughout. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast evaluates the roles of intravenously (IV) administered vancomycin and IV or orally (PO) administered linezolid for the empiric management of suspected or confirmed infections caused by methicillin-resistant Staphylococcus aureus (MRSA). We discuss and compare the positive and negative attributes of each drug and how those impact their places in the therapeutic management of MRSA infections. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode explores how pharmacy residency programs can remain agile in a rapidly evolving recruitment environment. Leaders from UNC Health discuss their experiences evaluating applicant interest, workforce priorities, program resources, and preceptor capacity to guide decisions around modifying, creating, consolidating, and general residency program agility and strategic workforce planning with postgraduate year 1 and 2 residency positions.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of Insights & Connections, ASHP Executive Vice President and CEO sits down with President Kim W. Benner for a candid conversation in which they discuss their shared vision for the organization, how ASHP can help our members tackle pharmacy's most pressing challenges, and how board and executive leadership are aligning to move ASHP and the profession forward. Listeners will hear directly from both leaders about what they are most looking forward to in the coming year, from exciting new ASHP initiatives to expanding opportunities for collaboration across the profession.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Looking to strengthen your organization's strategic planning efforts? Join the ASHP Foundation for a timely discussion on the challenges and opportunities shaping health-system pharmacy today. Learn from experienced leaders as they share how the Pharmacy Strategy Checklist on the new ASHP resource center can translate strategic goals into measurable results.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode provides health system pharmacists with comprehensive, evidence-based information about hepatitis B and vaccination. The discussion covers the historical burden of hepatitis B, clinical complications, current CDC/ACIP vaccination recommendations, clinical management protocols, public health reporting requirements, and the pharmacist's role in addressing caregiver questions. This episode clarifies current vaccination guidelines and equips pharmacists with the knowledge to support optimal immunization practices within their health systems.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Stephen Eckel and Michael Stepanovic discuss the AJHP Descriptive Report "The 2024 updated Basel Statements on the future of hospital pharmacy” with host and AJHP Editor in Chief Daniel Cobaugh.

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.